HIGHLIGHTS
- who: Neoadjuvant therapy- neutrophil-to-lymphocyte ratio- and colleagues from the committee of the Iran University of Medical Sciences (IRIUMS.FMD.REC.1398.231), and the study was conducted per the principles of the Declaration of Helsinki and current ethical guidelines. Treatment and Assessment To determine the pretreatment absolute neutrophil and lymphocyte count, at least two slides of peripheral blood smears were obtained from eligible participants before initiating neoCRT. The amounts were averaged for the final NLR. We advised the included patients not to smoke, exercise vigorously, or take anti-inflammatory drugs at least , hours prior to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.